(19)
(11) EP 1 284 976 A2

(12)

(88) Date of publication A3:
31.01.2002

(43) Date of publication:
26.02.2003 Bulletin 2003/09

(21) Application number: 01944118.7

(22) Date of filing: 27.04.2001
(51) International Patent Classification (IPC)7C07D 487/00
(86) International application number:
PCT/US0113/798
(87) International publication number:
WO 0108/1347 (01.11.2001 Gazette 2001/44)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 27.04.2000 US 559943
12.04.2001 US 833914

(71) Applicant: Abbott Laboratories
Abbott Park, IL 60064-6050 (US)

(72) Inventors:
  • SCHRIMPF, Michael, R.
    Grayslake, IL 60030 (US)
  • TIETJE, Karin, R.
    Mundelein, IL 60060 (US)
  • TOUPENCE, Richard, B.
    South Plainfield, NJ 07080 (US)
  • JI, Jianguo
    Libertyville, IL 60048 (US)
  • BASHA, Anwer
    Lake Forest, IL 60045 (US)
  • BUNNELLE, William, H.
    Mundelein, IL 60060 (US)
  • DAANEN, Jerome, F.
    Racine, WI 53405 (US)
  • PACE, Jennifer, M.
    Grayslake, IL 60030 (US)
  • SIPPY, Kevin, B.
    Antioch, IL 60002 (US)

(74) Representative: Modiano, Guido, Dr.-Ing. et al
Modiano, Josif, Pisanty & Staub,Baaderstrasse 3
80469 München
80469 München (DE)

   


(54) DIAZABICYCLIC CENTRAL NERVOUS SYSTEM ACTIVE AGENTS